1. Home
  2. AIMD vs STRR Comparison

AIMD vs STRR Comparison

Compare AIMD & STRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AIMD
  • STRR
  • Stock Information
  • Founded
  • AIMD 1984
  • STRR 1985
  • Country
  • AIMD United States
  • STRR United States
  • Employees
  • AIMD N/A
  • STRR N/A
  • Industry
  • AIMD Biotechnology: Pharmaceutical Preparations
  • STRR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • AIMD Health Care
  • STRR Health Care
  • Exchange
  • AIMD Nasdaq
  • STRR Nasdaq
  • Market Cap
  • AIMD 8.5M
  • STRR 7.0M
  • IPO Year
  • AIMD N/A
  • STRR N/A
  • Fundamental
  • Price
  • AIMD $0.62
  • STRR $2.19
  • Analyst Decision
  • AIMD
  • STRR
  • Analyst Count
  • AIMD 0
  • STRR 0
  • Target Price
  • AIMD N/A
  • STRR N/A
  • AVG Volume (30 Days)
  • AIMD 227.7K
  • STRR 6.2K
  • Earning Date
  • AIMD 03-07-2025
  • STRR 03-21-2025
  • Dividend Yield
  • AIMD N/A
  • STRR N/A
  • EPS Growth
  • AIMD N/A
  • STRR N/A
  • EPS
  • AIMD N/A
  • STRR N/A
  • Revenue
  • AIMD $40,633.00
  • STRR $50,375,000.00
  • Revenue This Year
  • AIMD N/A
  • STRR $15.58
  • Revenue Next Year
  • AIMD N/A
  • STRR $36.27
  • P/E Ratio
  • AIMD N/A
  • STRR N/A
  • Revenue Growth
  • AIMD N/A
  • STRR 2.22
  • 52 Week Low
  • AIMD $0.40
  • STRR $2.05
  • 52 Week High
  • AIMD $3.10
  • STRR $5.35
  • Technical
  • Relative Strength Index (RSI)
  • AIMD 47.20
  • STRR 49.56
  • Support Level
  • AIMD $0.56
  • STRR $2.10
  • Resistance Level
  • AIMD $0.77
  • STRR $2.23
  • Average True Range (ATR)
  • AIMD 0.06
  • STRR 0.10
  • MACD
  • AIMD -0.01
  • STRR 0.02
  • Stochastic Oscillator
  • AIMD 28.67
  • STRR 63.64

About AIMD Ainos Inc.

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

About STRR Star Equity Holdings Inc.

Star Equity Holdings Inc is a multi-industry diversified holding company with two segments: The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment holds corporate-owned real estate, which currently includes two manufacturing facilities in Maine that it leases back to KBS and manufacturing facility. The company derives maximum revenue from Construction Segment.

Share on Social Networks: